RE:RE:RE:SERNOVA paid a ridiculous amount for the PP SH... very good comment. Goes without saying that we are all happier today than a mere 4 months ago. Nice way of looking at the glass half full.
But the other half of the glass is empty. After so many years and so much clinical success, why is SVA still chasing fair value? Why have other companies (with less to show for) become the valuation benchmark SVA aspires to? SVA management has a role (I would say obligation) to better promote, sell and commercialize these successes.
We all understand stock market dynamics (consolidation, accumulation, etc...). The fact remains that shareholder value has considerably eroded over the last 4 weeks. Which means future revenue and valuation have not been communicated in a compelling enough way. In other words the market seems more / better reasons to sell than to buy.
I think it was Bio who asked the rhetorical question... " have the fundamentals changed?" No they haven't. The science is better than ever. But managements seeming inability to concretely transform this into shareholder value and then solidify this value does not seem to have changed either.
hopefully there will be a buyout rather than SVA wanting to go on their own (Nasdaq, etc...). Your shares may be in diamond hands, but we also need strong (management) hands on the wheel.
cheers